Normal view MARC view ISBD view

Molecular Docking Synthesis and Pharmacological Screening of Peroxisome Proliferator -activated receptor (PPAR) Y Agonists for treatment of type 2 Diabetes

By:

Material type: Text

Subject(s):

DDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre Reference	Reference	615.19 SHA (Browse shelf(Opens below))	Not For Loan		PDR00564
CD/DVD	NIMA Knowledge Centre Reference	Reference	615.19 SHA (Browse shelf(Opens below))	Not For Loan		PDR00564-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.19 SHA Design synthesis and Biological Evaluation of Ndvel Quinoxaline Derivatives Targeted to HIV-1GP120	615.19 SHA Design synthesis and Biological Evaluation of Ndvel Quinoxaline Derivatives Targeted to HIV-1GP120	615.19 SHA Molecular Docking Synthesis and Pharmacological Screening of Peroxisome Proliferator -activated receptor (PPAR) Y Agonists for treatment of type 2 Diabetes	615.19 SHA Molecular Docking Synthesis and Pharmacological Screening of Peroxisome Proliferator -activated receptor (PPAR) Y Agonists for treatment of type 2 Diabetes	615.19 SHA A Review on Drugs Used in COVID-19	615.19 SHA Overview on Prevention and Treatment of Covid-19 Through Traditional Therapy	615.19 SHA Types of Vaccines and Medicines Available in the Market for Covid-19	Next

Guided by Dr. Jignasa Savjani

There are no comments on this title.

to post a comment.